MaxCyte, Inc. (MXCT)
1.155
+0.02
(+1.32%)
USD |
NASDAQ |
Jun 08, 15:52
MaxCyte Shareholders Equity (Quarterly) : 167.89M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Repligen Corp. | 2.105B |
| Bio-Techne Corp. | 2.085B |
| BioLife Solutions, Inc. | 372.23M |
| MindWalk Holdings Corp. | 10.97M |
| Maravai Lifesciences Holdings, Inc. | 211.56M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 194.47M |
| Total Liabilities (Quarterly) | 26.59M |
| Debt to Equity Ratio | 0.1042 |
| Current Ratio | 12.04 |
| Net Debt Paydown Yield | 0.15% |